SeekIn and OncoInv have joined forces to make multi-cancer early detection (MCED) accessible in low- and middle-income countries (LMICs). SeekIn has developed several blood-based solutions to simplify and enhance cancer diagnosis and analysis. This technology can be...
Rare diseases are defined in the European Union as diseases with a prevalence of fewer than 5 cases out of a population of 10 000. In terms of cancers, 24% of all new cases are rare which means they belong to both categories of cancers and rare diseases. Joint Action...
With her book ‘The Biomedical Empire’, Barbara Katz Rothman, Professor of Sociology at City University New York, makes me a bit sad. She starts with that irritating remark: “Just imagine the financial crisis around the world if we just cured sickness”. She describes...
[Shenzhen, China, Sept. 15th, 2023] – SeekIn Inc., a leading company pioneering in blood-based cancer early detection, proudly announces the participation of Dr. Mao, CEO and Co-founder, in the highly anticipated BIOHK2023 conference. The CEO took the stage to...
Your body is as unique as your fingerprint. The way we maintain your health and treat diseases should also be unique and 100% compatible with your original genetic and epigenetic codes. At Ovital Institute we initiated personalised nutrition pilot studies on cancer...
